Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 2
1985 3
1986 1
1987 2
1988 1
1989 2
1990 2
1991 4
1992 5
1993 3
1994 4
1995 7
1996 8
1997 11
1998 7
1999 9
2000 17
2001 7
2002 9
2003 13
2004 11
2005 17
2006 10
2007 8
2008 8
2009 7
2010 10
2011 10
2012 12
2013 13
2014 10
2015 3
2016 1
2017 4
2018 2
2019 3
2020 3
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

244 results
Results by year
Filters applied: . Clear all
Page 1
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer.
Kazi A, Chen L, Xiang S, Vangipurapu R, Yang H, Beato F, Fang B, Williams TM, Husain K, Underwood P, Fleming JB, Malafa M, Welsh EA, Koomen J, Trevino J, Sebti SM. Kazi A, et al. Among authors: sebti sm. Clin Cancer Res. 2021 Jul 15;27(14):4012-4024. doi: 10.1158/1078-0432.CCR-20-4781. Epub 2021 Apr 20. Clin Cancer Res. 2021. PMID: 33879459 Free PMC article.
Bleomycin.
Lazo JS, Sebti SM. Lazo JS, et al. Among authors: sebti sm. Cancer Chemother Biol Response Modif. 1997;17:40-5. Cancer Chemother Biol Response Modif. 1997. PMID: 9551207 Review. No abstract available.
Bleomycin.
Lazo JS, Sebti SM. Lazo JS, et al. Among authors: sebti sm. Cancer Chemother Biol Response Modif. 1994;15:44-50. Cancer Chemother Biol Response Modif. 1994. PMID: 7540032 Review. No abstract available.
Bleomycins.
Lazo JS, Sebti SM. Lazo JS, et al. Among authors: sebti sm. Cancer Chemother Biol Response Modif. 1993;14:37-44. Cancer Chemother Biol Response Modif. 1993. PMID: 7508730 Review. No abstract available.
Bleomycins.
Lazo JS, Sebti SM. Lazo JS, et al. Among authors: sebti sm. Cancer Chemother Biol Response Modif. 1991;12:51-8. Cancer Chemother Biol Response Modif. 1991. PMID: 1718378 Review. No abstract available.
Farnesyltransferase inhibitors.
Sebti SM, Adjei AA. Sebti SM, et al. Semin Oncol. 2004 Feb;31(1 Suppl 1):28-39. doi: 10.1053/j.seminoncol.2003.12.012. Semin Oncol. 2004. PMID: 14981578 Review.
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function.
Boucher JC, Li G, Kotani H, Cabral ML, Morrissey D, Lee SB, Spitler K, Beatty NJ, Cervantes EV, Shrestha B, Yu B, Kazi A, Wang X, Sebti SM, Davila ML. Boucher JC, et al. Among authors: sebti sm. Cancer Immunol Res. 2021 Jan;9(1):62-74. doi: 10.1158/2326-6066.CIR-20-0253. Epub 2020 Nov 13. Cancer Immunol Res. 2021. PMID: 33188139 Free PMC article.
Bleomycin.
Lazo JS, Sebti SM, Schellens JH. Lazo JS, et al. Among authors: sebti sm. Cancer Chemother Biol Response Modif. 1996;16:39-47. Cancer Chemother Biol Response Modif. 1996. PMID: 8639392 Review. No abstract available.
244 results